| 1 |
35086846 | In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human. | 2022 Apr |
1 |
| 2 |
31405030 | Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. | 2019 Aug 9 |
2 |
| 3 |
29268130 | Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors. | 2018 Jan 20 |
2 |
| 4 |
27586888 | Differential diagnosis of lipoic acid synthesis defects. | 2016 Nov |
2 |
| 5 |
24962578 | Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth. | 2014 Aug 1 |
3 |
| 6 |
24341803 | Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase. | 2013 Dec 17 |
1 |
| 7 |
16989905 | Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. | 2007 Jan |
1 |
| 8 |
14715435 | Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. | 2003 |
1 |
| 9 |
1691756 | Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. | 1990 May 1 |
2 |
| 10 |
2480138 | Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis. | 1989 Sep |
1 |
| 11 |
2658106 | Primary biliary cirrhosis: current knowledge, perspectives, and future directions. | 1989 May |
1 |